Follow up period after HIFU | 7 - 159 months (median 46.5) | No. of patients |
PSA nadir (PSA ng/ml) | 0.008 - 0.789 (median 0.088) | |
1 - 21 months (median 1.5) | ||
<0.01 | 4 | |
0.01 - <0.2 | 10 | |
0.2 - <0.4 | 1 | |
≥0.4 | 1 | |
Disease free survival rate | 1 year 50.0% | |
2 year 37.5 | ||
3 year 31.3 | ||
4 year 31.3 | ||
5 year 31.3 | ||
PSA result of salvage HIFU | ||
<0.2 | 4 | |
<0.4 over 24 months | 5 | |
<0.4 under12 months | 4 | |
>0.4 under 12 months | 3 | |
Adverse effects at 1 - 3 months after HIFU | ||
Difficult voiding | G1 2, G2 3 | |
Urinary incontinence | G1 2, G2 1 | |
Recto-urethral fistula | 0 |